ENST00000622386.2:c.-467-9864T>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000622386.2(KMT2E):c.-467-9864T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.47 in 152,002 control chromosomes in the GnomAD database, including 16,950 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.47 ( 16950 hom., cov: 32)
Consequence
KMT2E
ENST00000622386.2 intron
ENST00000622386.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.234
Publications
6 publications found
Genes affected
KMT2E (HGNC:18541): (lysine methyltransferase 2E (inactive)) This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a protein with an N-terminal PHD zinc finger and a central SET domain. Overexpression of the protein inhibits cell cycle progression. Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
KMT2E-AS1 (HGNC:40845): (KMT2E antisense RNA 1)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.507 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KMT2E | ENST00000622386.2 | c.-467-9864T>C | intron_variant | Intron 1 of 12 | 5 | ENSP00000482147.2 | ||||
KMT2E | ENST00000415513.1 | n.609-9864T>C | intron_variant | Intron 1 of 1 | 2 | |||||
KMT2E-AS1 | ENST00000450686.2 | n.334+1580A>G | intron_variant | Intron 2 of 2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.470 AC: 71335AN: 151882Hom.: 16927 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
71335
AN:
151882
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.470 AC: 71398AN: 152002Hom.: 16950 Cov.: 32 AF XY: 0.468 AC XY: 34784AN XY: 74296 show subpopulations
GnomAD4 genome
AF:
AC:
71398
AN:
152002
Hom.:
Cov.:
32
AF XY:
AC XY:
34784
AN XY:
74296
show subpopulations
African (AFR)
AF:
AC:
21253
AN:
41430
American (AMR)
AF:
AC:
7385
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
1542
AN:
3466
East Asian (EAS)
AF:
AC:
2466
AN:
5166
South Asian (SAS)
AF:
AC:
1762
AN:
4814
European-Finnish (FIN)
AF:
AC:
4673
AN:
10566
Middle Eastern (MID)
AF:
AC:
139
AN:
294
European-Non Finnish (NFE)
AF:
AC:
30701
AN:
67954
Other (OTH)
AF:
AC:
1001
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1913
3826
5740
7653
9566
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
648
1296
1944
2592
3240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1467
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.